Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mutational signatures

ABSTRACT: Mutational signatures

PROVIDER: PRJEB60585 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR11011331_1.fastq.gz	Fastqsanger.gz
	ERR11011331_2.fastq.gz	Fastqsanger.gz
	ERR11261500_1.fastq.gz	Fastqsanger.gz
	ERR11261500_2.fastq.gz	Fastqsanger.gz
	ERR11262400_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 558

Similar Datasets

mutational signatures of aflatoxin

Project description:Genome-scale mutational signatures of aflatoxin in cells, mice and human tumor

| PRJEB20736 | ENA

APOBEC3A induces cancer-specific mutational signatures in human genomes

Project description:APOBEC3A induces cancer-specific mutational signatures in human genomes

| PRJEB13145 | ENA

Mutational signatures of colorectal cancers according to distinct computational workflows

Project description:Mutational signatures of colorectal cancers according to distinct computational workflows

| PRJEB61897 | ENA

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma

Project description:Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma

| PRJNA667701 | ENA

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [methylation]

Project description:Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [methylation]

| PRJNA667702 | ENA

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [RNA]

Project description:Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [RNA]

| PRJNA667801 | ENA

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [WES]

Project description:Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [WES]

| PRJNA667802 | ENA

Genome Sequencing of Gastric Cancer Reveals Diverse Mutational and Pathogen Signatures

Project description:We leveraged massively parallel sequencing approach to comprehensively characterize the spectrum of somatic mutations and genomic rearrangements in two intestinal-type gastric adenocarcinomas from patients with and without active Helicobacter pylori infections. The tumours exhibited distinct patterns of genomic changes with more than 16,000 somatic substitutions on average, focal amplifications and rearrangements in the non-active infected tumour and a 7-fold enrichment of micro-deletions in the infected tumour. Paired-end sequences from large insert libraries revealed the structure and origins of large amplicons, including one involving the oncogene KRAS. The mutational frequencies of the tumours revealed patterns of H. pylori infection and mutagenesis and a unique exome signature, providing insights into mechanisms that define the mutational landscape of gastric cancer. For the tumour with active infection, we also reconstructed the genome of the pathogenic H. pylori strain from the raw sequence reads, demonstrating the power of whole-genome shotgun sequencing for simultaneously characterizing the tumour and its associated carcinogen genome.

2012-12-05 | GSE30833 | GEO

Mutational signatures of aflatoxin

Project description:Aflatoxin B1 (AFB1) is a mutagen and IARC (International Agency for Research on Cancer) Group 1 carcinogen that causes hepatocellular carcinoma (HCC). Here we present the first whole genome data on the mutational signatures of AFB1 exposure from a total of > 40,000 mutations in four experimental systems: two different human cell lines, and in liver tumors in wild-type mice and in mice that carried a hepatitis B surface antigen transgene – this to model the multiplicative effects of aflatoxin exposure and hepatitis B in causing HCC. AFB1 mutational signatures from all four experimental systems were remarkably similar. We integrated the experimental mutational signatures with data from newly-sequenced HCCs from Qidong County, China, a region of well-studied aflatoxin exposure. This indicated that COSMIC mutational signature 24, previously hypothesized to stem from aflatoxin exposure, indeed likely represents AFB1 exposure, possibly combined with other exposures. Among published somatic mutation data, we found evidence of AFB1 exposure in 0.7% of HCCs treated in North America, 1% of HCCs from Japan, but 16% of HCCs from Hong Kong. Thus, aflatoxin exposure apparently remains a substantial public health issue in some areas. This aspect of our study exemplifies the promise of future widespread resequencing of tumor genomes in providing new insights into the contribution of mutagenic exposures to cancer incidence.

| EGAS00001002490 | EGA

Gastric Mutational Signatures GMS

Project description:This study aims to characterise the mutation burdens and signatures of adult stem cells derived from different regions of the stomach in order to gain insight into the causes and preclinical evolution of the diverse cancer subtypes. Clonal populations of cells from different anatomical locations of the stomach will be derived through organoid culture and/or laser microdissection and interrogated by whole genome sequencing and/or targeted pulldown. A total of circa 300 samples from 20 Â– 30 donors (cancer and non-cancer patients undergoing total/partial gastrectomy) will be analysed for mutational burden and signatures and genomic findings correlated with topology, age, risk factors and different stages of pre-neoplastic or neoplastic progression.

| EGAS00001002939 | EGA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data